Benign prostatic hyperplasia

Last updated: November 01, 2022

Benign prostatic hyperplasia

Watched

Watched

Uterine fibroid
Vulvovaginitis: Clinical
Sexually transmitted infections: Clinical
Ectopic pregnancy
Miscarriage
Infertility: Clinical
Routine prenatal care: Clinical
Pregnancy
Contraception: Clinical
Development of twins
Postpartum hemorrhage
Development of the placenta
Postpartum hemorrhage: Clinical
Placenta previa
Premature rupture of membranes: Clinical
Stages of labor
Abnormal labor: Clinical
Fetal circulation
Breastfeeding
Anatomy clinical correlates: Female pelvis and perineum
Ovarian cysts, cancer, and other adnexal masses: Clinical
Endometrial hyperplasia and cancer: Clinical
Preoperative evaluation: Clinical
General anesthetics
Postoperative evaluation: Clinical
Opioid agonists, mixed agonist-antagonists and partial agonists
Local anesthetics
Neuromuscular blockers
Maintaining an airway
Respiratory system anatomy and physiology
Acute respiratory distress syndrome: Clinical
Renal tubular acidosis
Renal tubular acidosis: Pathology review
Hyperparathyroidism
Hemochromatosis
Graves disease
Thyroid eye disease (NORD)
Hashimoto thyroiditis
Varicella zoster virus
Lyme Disease
Borrelia burgdorferi (Lyme disease)
Alcohol use disorder
Wernicke-Korsakoff syndrome
Cirrhosis
Alcohol-associated liver disease
Cirrhosis: Clinical
Reactive arthritis
Bone tumors
Seizures and epilepsy
Seizures: Pathology review
Anticonvulsants and anxiolytics: Benzodiazepines
Ischemic stroke
Anatomy clinical correlates: Cerebral hemispheres
Chest trauma: Clinical
Peripheral nervous system histology
Abdominal trauma: Clinical
Benign liver tumors
Abdominal hernias
Anatomy of the anterolateral abdominal wall
Peripheral vascular disease: Clinical
Diverticular disease: Clinical
Thrombotic thrombocytopenic purpura
Hemolytic-uremic syndrome
Disseminated intravascular coagulation
Thyroid nodules and thyroid cancer: Clinical
Thyroglossal duct cyst
Anatomy of the thyroid and parathyroid glands
Thyroid and parathyroid gland histology
Thyroid cancer
Concussion and traumatic brain injury
Traumatic brain injury: Pathology review
Intracerebral hemorrhage
Ascending and descending spinal tracts
Introduction to the somatic and autonomic nervous systems
Introduction to the central and peripheral nervous systems
Anatomy clinical correlates: Spinal cord pathways
Kidney stones: Pathology review
Chronic venous insufficiency
Peptic ulcer
Cardiac tamponade
Pancreatitis: Pathology review
Pancreatitis: Clinical
Chronic pancreatitis
Systemic lupus erythematosus (SLE): Clinical
Hypokalemia: Clinical
Hypokalemia
Pancreatic cancer
Carpal tunnel syndrome
Anatomy clinical correlates: Median, ulnar and radial nerves
Wound healing
Benign prostatic hyperplasia
Colorectal polyps
Sickle cell disease (NORD)
Alpha-thalassemia
Beta-thalassemia
Breast cancer: Pathology review
Benign breast conditions: Pathology review
Hirschsprung disease
Bowel obstruction
Volvulus
Shock: Pathology review
Neck trauma: Clinical
Portal hypertension
Leg ulcers: Clinical
Slipped capital femoral epiphysis

Transcript

Watch video only

In benign prostatic hyperplasia, or BPH, prostatic refers to the prostate gland, hyperplasia means an increase in the number of cells, and benign means that these cells aren’t malignant, so they don’t invade neighboring tissues.

So, benign prostatic hyperplasia is the non-cancerous growth of the prostate gland.

This condition is common in men over 50, and is often considered a normal part of aging.

The prostate is a small gland, about the size and shape of a walnut, that sits under the bladder and in front of the rectum.

The urethra which is the tube through which urine leaves the bladder, goes through the prostate before reaching the penis.

And that part of the urethra is called the prostatic urethra.

The prostate is covered by a capsule of tough connective tissue and smooth muscle.

Beneath this layer, the prostate can be divided into a few zones.

The peripheral zone, which is the outermost posterior section, is the largest of the zone and contain about 70% of the prostate’s glandular tissue.

Moving inward, the next section is the central zone which contains about 25% of the glandular tissue as well as the ejaculatory ducts that join with the prostatic urethra.

Last, is the transitional zone, which contains around 5% of the glandular tissue as well as a portion of the prostatic urethra.

The transitional zone gets its name because it contains transitional cells which are also found in the bladder.

At the microscopic level, each of the tiny glands that make up the prostate is surrounded by a basement membrane made largely of collagen.

Sitting within that basement membrane, is a ring of cube-shaped basal cells as well as a few neuroendocrine cells interspersed throughout.

Finally, there’s an inner ring of luminal columnar cells, which are within the lumen or center of the gland. Luminal cells secrete substances into the prostatic fluid, that make it slightly alkaline that give it nutrients which nourish the sperm and help it survive in the acidic environment of the vagina.

During an ejaculation, sperm leave the testes, travel through the vas deferens, into the ejaculatory ducts, and travel through the prostatic urethra.

Smooth muscles in the prostate contract and push the prostatic fluid into the urethra where it joins the sperm as well as the semen which is the fluid that comes from the seminal vesicles.

The luminal cells also produce prostate specific antigen, or PSA, which helps to liquefy the gel-like semen after ejaculation, thereby freeing the sperm to swim.

The basal cells and luminal cells of the prostate rely on stimulation from androgens, or male sex hormones, for survival.

The androgens include testosterone, which is produced by the testicles, and dihydrotestosterone, which is produced in the prostate itself.

This androgen is produced by the prostatic enzyme 5α-reductase which converts testosterone into the more potent dihydrotestosterone.

Since androgens are steroids, so they can cross the cell membrane and bind to the androgen receptors within the cell’s nucleus.

This inhibits the apoptosis of or programmed cell death, allowing luminal and basal cells in the prostate to keep growing and multiplying.

Dihydrotestosterone is ten times more potent than testosterone because it can bind to androgen receptors much longer.

Now, after the age of 30, men produce about 1% less testosterone per year.

But for unclear reasons, 5α-reductase activity increases with age, so even with less testosterone, there could be an increase in dihydrotestosterone.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine 20th Ed" McGraw Hill / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine, 8e" McGraw Hill (2019)
  4. "Current Medical Diagnosis and Treatment 2020" McGraw Hill (2020)
  5. "Management of Benign Prostatic Hyperplasia" Annual Review of Medicine (2016)
  6. "Post-micturition dribble in men: causes and treatment" Nursing Standard (2008)
  7. "Post-micturition dribble in men: causes and treatment" Nursing Standard (2008)